| Literature DB >> 34936047 |
Radwa N Morgan1, Sarra E Saleh2, Khaled M Aboshanab3, Hala A Farrag1.
Abstract
This work explores the ADP-ribosyltransferase activity of Pseudomonas (P.) aeruginosa exotoxin A using the guanyl hydrazone derivative, nitrobenzylidine aminoguanidine (NBAG) and the impact of gamma radiation on its efficacy. Unlike the conventional detection methods, NBAG was used as the acceptor of ADP ribose moiety instead of wheat germ extract elongation factor 2. Exotoxin A was extracted from P. aeruginosa clinical isolates and screened for toxA gene using standard PCR. NBAG was synthesized using aminoguanidine bicarbonate and 4-nitrobenzaldehyde and its identity has been confirmed by UV, FTIR, Mass and 13C-NMR spectroscopy. The ADP-ribosyl transferase activity of exotoxin A on NBAG in the presence of Nicotinamide adenine dinucleotide (NAD+) was recorded using UV spectroscopy and HPLC. In vitro ADP-ribosyl transferase activity of exotoxin A protein extract was also explored by monitoring its cytotoxicity on Hep-2 cells using sulforhodamine B cytotoxicity assay. Bacterial broths were irradiated at 5, 10, 15, 24 Gy and exotoxin A protein extract activity were assessed post exposure. Exotoxin A extract exerted an ADP-ribosyltransferase ability which was depicted by the appearance of a new ʎmax after the addition of exotoxin A to NBAG/NAD+ mixture, fragmentation of NAD+ and development of new peaks in HPLC chromatograms. Intracellular enzyme activity was confirmed by the prominent cytotoxic effects of exotoxin A extract on cultured cells. In conclusion, the activity of Exotoxin A can be monitored via its ADP-ribosyltransferase activity and low doses of gamma radiation reduced its activity. Therefore, coupling radiotherapy with exotoxin A in cancer therapy should be carefully monitored.Entities:
Keywords: ADP ribosyl transferase activity; Cytotoxicity; Exotoxin A; Gamma radiation; HPLC; NBAG
Year: 2021 PMID: 34936047 PMCID: PMC8695647 DOI: 10.1186/s13568-021-01332-3
Source DB: PubMed Journal: AMB Express ISSN: 2191-0855 Impact factor: 3.298
Fig. 1Absorbance spectra of exotoxin A extract alone and the shift in wavelength associated with the addition of exotoxin to NBAG/NAD+ mixture
Fig. 2Cytotoxic effects of exotoxin A protein extract at 100 µg/ml on cultured Hep2 cells versus control untreated Hep2 cells
Fig. 3Cytotoxic effect of gamma irradiated exotoxin A protein extract at 100 µg/ml on cultured Hep2 cells versus control untreated Hep2 cells
Fig. 4Plot of percentage viability against the concentration of protein extracts (µg/ml) prior and post exposure to low doses gamma radiation and IC50 values
Fig. 5HPLC Chromatogram for standard and exotoxin A protein extract treated NBAG reactions at 301 nm
Fig. 6HPLC Chromatogram for standard and exotoxin A protein extract treated NBAG reactions at 254 nm
Concentration of ADP ribosylated NBAG and percent ADP ribosylated NBAG formed post exposure to exotoxin A protein extract at 301 nm
| Retention time at 301 nm | ʎ max of the minor peaks | Peak area | ADP-ribosylated NBAG formed in M | Percent ADP ribosylated NBAG formed | |
|---|---|---|---|---|---|
| PA 1 NBAG peak | 9.33 | 329/227 | 18,583,078 | 0.01 | |
| PA 1 new peaks | 12.16 | 228/340 | 45,548 | 1.46 × 10–5 | 0.31 |
| 12.29 | 229/327 | 53,355 | 1.71 × 10–5 | ||
| PA 5 NBAG peak | 9.47 | 304/325/230 | 30,528,050 | 0.01 | |
| PA 5 new peaks | 12.29 | 225/327 | 35,634 | 1.16 × 10–5 | 0.23 |
| 13.58 | 226/268 | 33,613 | 1.101 × 10–5 | ||
| PA 16 NBAG peak | 9.32 | 331/228 | 21,872,503 | 0.01 | |
| PA 16 new peaks | 11.44 | 225/327 | 77,762 | 3.55 × 10–5 | 1.71 |
| 11.6 | 225/327 | 60,768 | 2.78 × 10–5 | ||
| 12.05 | 226/339 | 123,413 | 5.64 × 10–5 | ||
| 12.31 | 226/327 | 63,771 | 2.91 × 10–5 | ||
| 12.46 | 226/327 | 49,347 | 2.26 × 10–5 | ||
| 11.44 | 225/327 | 77,762 | 3.55 × 10–5 | ||
| 11.6 | 225/327 | 60,768 | 2.77 × 10–5 | ||
| 12.05 | 226/339 | 123,413 | 5.64 × 10–5 | ||
| PA 22 NBAG peak | 9.32 | 332 | 18,955,192 | 0.01 | |
| PA 22 new peaks | 11.17 | 204/266/329/367/288 | 3050 | 1.61 × 10–6 | 0.85 |
| 12.08 | 205/340 | 62,448 | 3.29 × 10–5 | ||
| 12.23 | 206/329 | 22,983 | 1.212 × 10–5 | ||
| 12.4 | 206/265/329/368 | 3215 | 1.7 × 10–6 | ||
| 12.92 | 208/265/329/369 | 2151 | 1.13 × 10–6 | ||
| 13.17 | 208/323/369 | 6124 | 3.23 × 10–6 | ||
| PA 35 NBAG peak | 9.43 | 334/231 | 31,719,819 | 0.01 | |
| PA 35 new peaks | 12.16 | 224/339 | 44,585 | 1.41 × 10–5 | 0.42 |
| 12.29 | 225/327 | 48,434 | 1.53 × 10–5 | ||
| 13.58 | 225/268 | 42,470 | 1.34 × 10–5 | ||
| PA 39 NBAG peak | 9.33 | 329/227 | 18,583,078 | 0.01 | |
| PA 39 new peaks | 12.08 | 226/340 | 62,029 | 3.34 × 10–5 | 0.33 |
Conc. = concentration; Concentration of ADP ribosylated NBAG = (area unknown/area known) × concentration of known (NBAG); Percent reduction in NBAG conc. = (total concentration of ADP ribosylated NBAG/concentration of NBAG) × 100
Fig. 7FTIR spectrum for the precipitate formed post exposure of NBAG and NAD+ to exotoxin A protein Extract
Concentration of ADP ribosylated NBAG formed post exposure to irradiated exotoxin A protein extract and percent reduction compared to the un-irradiated exotoxin A
| Radiation dosage | Retention time at 301 nm | Peak area | ʎ max | Conc. of unknown (ADP-ribosylated products) | Percent of ADP-ribosylated products formed | Percent reduction in the amount of ADP-ribosylated product formed |
|---|---|---|---|---|---|---|
| 9.38 | 11,632,146 | 314/228 | 0.01 | |||
| 10.6 | 1300 | 223/291/327 | 1.118 × 10–6 | 0.73 | 0.98 | |
| 12.14 | 11,518 | 225/340 | 9.902 × 10–6 | |||
| 12.24 | 17,167 | 225/327 | 1.476 × 10–6 | |||
| 13.17 | 2415 | 225 | 2.076 × 10–6 | |||
| 13.54 | 8416 | 226 | 7.235 × 10–6 | |||
| 9.34 | 10,739,513 | 325/225 | 0.01 | |||
| 10.56 | 2654 | 222/291/269/327 | 2.5 × 10–6 | 0.71 | 0.14 | |
| 12.08 | 21,741 | 225/340 | 2.5 × 10–6 | |||
| 12.25 | 16,007 | 226/331 | 1.49 × 10–5 | |||
| 12.94 | 1606 | 226/331 | 1.5 × 10–6 | |||
| 13.19 | 2474 | 227/327 | 2.3 × 10–6 | |||
| 13.56 | 5403 | 227 | 5 × 10–6 | |||
| 13.72 | 4247 | 228/327 | 4 × 10–6 | |||
Conc. of ADP ribosylated NBAG = (area unknown/area known) × conc. of NBAG; Percent ADP ribosylated NBAG formed = (total conc. of ADP ribosylated NBAG/conc. of NBAG) × 100; Percent reduction compared to un-irradiated strain = percent of ADP ribosylated NBAG formed for un-irradiated – percent of ADP ribosylated NBAG formed for irradiated
Fig. 8HPLC Chromatogram for standard and irradiated exotoxin A protein extract treated NBAG reactions at 301 nm